Problems You Face Every Day
Traditional approaches to sickle cell tracking leave critical gaps that cost lives and waste resources.
Limited Real-World Data
Clinical trial data captures only a fraction of the SCD patient experience. Real-world prescribing patterns and outcomes in African populations remain largely invisible.
Difficult Trial Recruitment
Identifying eligible patients for SCD clinical trials across multiple sites in Africa is expensive, slow, and often results in under-enrolled studies.
Post-Market Surveillance Gaps
Once drugs reach market, tracking real-world adherence, side effects, and long-term outcomes across African populations requires infrastructure that does not exist.
How Tracka Transforms Your Workflow
Purpose-built for sickle cell disease management with the tools your team actually needs.
Hydroxyurea Monitoring Data
Access longitudinal data on HU prescriptions, dose titrations, lab monitoring, adherence rates, and clinical outcomes across thousands of patients.
Prescribing Pattern Analysis
Understand how physicians across different regions prescribe SCD medications. Identify adoption barriers, dosing trends, and switching patterns.
Trial-Ready Cohorts
Build eligible patient lists for clinical trials using our cohort builder. Filter by genotype, age, crisis frequency, medication history, and geography.
Enterprise API Access
Programmatically query anonymized patient data through our REST API. Integrate real-world evidence into your regulatory submissions and HEOR models.
Genotype-Specific Outcomes
Compare treatment outcomes across all 9 hemoglobin genotypes. Understand how SS, SC, and S-beta-thal patients respond differently to therapies.
Post-Market Surveillance
Track real-world drug performance after launch. Monitor adverse events, effectiveness signals, and patient-reported outcomes at population scale.
Everything You Need, Nothing You Don't
- Longitudinal hydroxyurea monitoring data including dosing, adherence, and lab results
- Prescribing pattern analytics across 342 facilities with regional comparisons
- Cohort builder for identifying trial-eligible patients by any clinical or demographic criteria
- Enterprise API with anonymized data feeds for HEOR modeling and regulatory submissions
- Genotype-stratified outcome analysis for all 9 tracked hemoglobin genotypes
- Crisis frequency data correlated with treatment regimens and adherence levels
- Clinical-grade anonymization ensures compliance with international data protection standards
- Custom data partnerships available for long-term pharmacovigilance programs
Clinical Data Points
Genotypes Tracked
Crisis Events Recorded
Contributing Facilities